A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

NCT01056510 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

357

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphocytic Leukemia, Chronic

Interventions

DRUG: bendamustine
DRUG: chlorambucil
DRUG: rituximab [MabThera/Rituxan]

Sponsor

Hoffmann-La Roche